In participants with baseline HIV-1 RNA more than 100000 copies/ml ( n = 276 ) , RPV/FTC/TDF demonstrated noninferior efficacy compared with EFV/FTC/TDF ( 79.9 vs. 81.7 % , respectively , difference -1.8 % , 95 % CI -11.1 to 7.5 % ) .